236 related articles for article (PubMed ID: 15290815)
1. Drugmakers prefer silence on test data; firms violate US law by not registering trials.
Vedantam S
Washington Post; 2004 Jul; ():A1, A4. PubMed ID: 15290815
[No Abstract] [Full Text] [Related]
2. Glaxo agrees to post results of drug trials on web site.
Harris G
N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364
[No Abstract] [Full Text] [Related]
3. Despite vow, drug makers still withhold data.
Berenson A
N Y Times Web; 2005 May; ():A1, C3. PubMed ID: 15952254
[No Abstract] [Full Text] [Related]
4. Registration of clinical trials--voluntary or mandatory?
Steinbrook R
N Engl J Med; 2004 Oct; 351(18):1820-2. PubMed ID: 15509812
[No Abstract] [Full Text] [Related]
5. Results of drug trials can mystify doctors through omission: some professional groups demand public listing of all test outcomes.
Meier B
N Y Times Web; 2004 Jul; ():C1, C3. PubMed ID: 15290807
[No Abstract] [Full Text] [Related]
6. Public registration of clinical trials.
Steinbrook R
N Engl J Med; 2004 Jul; 351(4):315-7. PubMed ID: 15269307
[No Abstract] [Full Text] [Related]
7. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL; Reig LP
Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
[No Abstract] [Full Text] [Related]
8. Congress may force drug firms to reveal clinical trial data.
Check E
Nature; 2004 Sep; 431(7006):232. PubMed ID: 15371992
[No Abstract] [Full Text] [Related]
9. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov.
Law MR; Kawasumi Y; Morgan SG
Health Aff (Millwood); 2011 Dec; 30(12):2338-45. PubMed ID: 22147862
[TBL] [Abstract][Full Text] [Related]
10. Expose your clinical thinking.
Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286628
[No Abstract] [Full Text] [Related]
11. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
Hirsch L
Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
[TBL] [Abstract][Full Text] [Related]
12. Medical editors likely to call for registration of drug tests at outset.
Meier B
N Y Times Web; 2004 Sep; ():C1, C4. PubMed ID: 15742506
[No Abstract] [Full Text] [Related]
13. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
Cohen K; Cormier JW; Davar MV
J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261
[No Abstract] [Full Text] [Related]
14. Trial-results reporting and academic medical centers.
Zarin DA; Tse T; Ross JS
N Engl J Med; 2015 Jun; 372(24):2371-2. PubMed ID: 25992618
[No Abstract] [Full Text] [Related]
15. Guidance on financial disclosure requirements.
Maloney DM
Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833562
[No Abstract] [Full Text] [Related]
16. Compliance with results reporting at ClinicalTrials.gov.
Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
[TBL] [Abstract][Full Text] [Related]
17. Institutional review boards and clinical trials registry.
Maloney DM
Hum Res Rep; 2004 Nov; 19(11):3. PubMed ID: 15675087
[No Abstract] [Full Text] [Related]
18. Drug giants fail to name compounds in trial database.
Wadman M
Nature; 2005 Jun; 435(7042):548. PubMed ID: 15931185
[No Abstract] [Full Text] [Related]
19. Implementing registries and results databases of clinical trials: is there a side effect?
Dahm M; González P; Porteiro N
Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):247-51. PubMed ID: 20545589
[TBL] [Abstract][Full Text] [Related]
20. Closing a loophole in the FDA Amendments Act.
Turner EH
Science; 2008 Oct; 322(5898):44-6. PubMed ID: 18832629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
